News
BIBC Translation and Formulation Core – Coming Soon
June 14, 2023BIBC Formulation and Translation Core
Read Story
2022 Technologies in Brain Cancer Symposium
October 24, 2022Thank you to all those that participated, sponsored, and attended our inaugural Technologies in Brain Cancer Symposium. We could not have done it without you!
Read Story
BIBC Tenure Track Faculty Positions Open
July 21, 2021The University of Michigan BioInnovations in Brain Cancer Program (BIBC) is currently soliciting applications for tenure track faculty positions at any level. We welcome applications from outstanding scientists with expertise in any areas pertaining to translational or basic brain cancer biology research and/or development of cutting-edge technological approaches for treatment.
Read Story
S.Nagrath Lab develops new microfluidic chip to capture and investigate exosomes
January 29, 2021The Sunitha Nagrath lab reports on their work to capture natural killer cells and harvest exosomes to investigate their potential for battling cancer cells.
Read Story
BI Startup EVOQ Therapeutics inks agreement with Amgen
January 14, 2021Under this license and collaboration agreement, EVOQ and Amgen will work on discovery and development of drugs for autoimmune disorders.
Read Story
Anna Schwendeman Promoted
January 1, 2021Congratulations to Anna Schwendeman on being named the William I. Higuchi Collegiate Professor of Pharmacy!
FDA awards $5M to establish new Center for Research on Complex Generics
September 30, 2020Researchers from the University of Michigan and the University of Maryland were awarded a $5 million grant to establish a new Center for Research on Complex Generics. BI Faculty Professor Anna Schwendeman will be the center co-director along with Professor James Polli from the University of Maryland.
The center is funded by the FDA Office of Generic Drugs and aims at bringing complex generic drugs and drug products to market faster.
Read Story
Three New Startups Launched in FY20
September 11, 2020BI faculty members were part of three new startup companies launched in FY20.
Read Story
Study by Deepak Nagrath and Sunitha Nagrath Labs propose new strategy to target pancreatic cancer
July 9, 2020Study by Deepak Nagrath and Sunitha Nagrath Labs propose new strategy to target pancreatic cancer
Read Story
Moon Awarded Michigan Drug Discovery Grant
June 18, 2020Congratulations to James Moon who received a pilot grant from Michigan Drug Discovery to continue his ongoing work to develop immunotherapy agents for the treatment of cancer.
Read Story
Deepak Nagrath Named Forbes Scholar
May 7, 2020Congratulations to Deepak Nagrath on being named one of the Rogel Cancer Center’s 2020 Forbes Scholars. Nagrath is using genetic and clinical data from patients to identify mutations in ovarian cancer cells.
Read Story